GCP
TWST icon

GSA Capital Partners’s Twist Bioscience TWST Stock Holding History

GSA Capital Partners’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,994
Closed -$226K – 2041
2024
Q3 		$226K Sell
4,994
-880
-15% -$41.9K 0.02% 1368
2024
Q2 		$289K Sell
5,874
-11,411
-66% -$465K 0.02% 1297
2024
Q1 		$593K Sell
17,285
-25,858
-60% -$933K 0.05% 779
2023
Q4 		$1.59M Buy
+43,143
New +$998K 0.13% 199
2023
Q1 		– Sell
-30,502
Closed -$726K – 1944
2022
Q4 		$726K Buy
+30,502
New +$884K 0.09% 383
2020
Q4 		– Sell
-2,940
Closed -$223K – 1607
2020
Q3 		$223K Buy
+2,940
New +$183K 0.04% 939

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GSA Capital Partners's TWST Position: Q4 2024 in Review

GSA Capital Partners sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 4,994 shares — an estimated $226K sold.

GSA Capital Partners first reported a position in TWST in Q3 2020 and held it in 6 quarters. The position peaked at $1.59M in Q4 2023. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

  • GSA Capital Partners reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
  • GSA Capital Partners sold 4,994 Twist Bioscience shares in Q4 2024, an estimated $226K.
  • GSA Capital Partners first reported a position in Twist Bioscience in Q3 2020 and held it in 6 quarters.
  • GSA Capital Partners's Twist Bioscience position peaked at $1.59M in Q4 2023.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.